State Street’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,759
Closed -$42.6K 4328
2025
Q4
$42.6K Hold
7,759
﹤0.01% 4180
2025
Q3
$31K Hold
7,759
﹤0.01% 4211
2025
Q2
$21K Hold
7,759
﹤0.01% 4200
2025
Q1
$40.6K Hold
7,759
﹤0.01% 4124
2024
Q4
$59.6K Hold
7,759
﹤0.01% 4082
2024
Q3
$72.6K Sell
7,759
-394
-5% -$3.8K ﹤0.01% 4042
2024
Q2
$87.4K Sell
8,153
-56,062
-87% -$760K ﹤0.01% 4044
2024
Q1
$950K Buy
64,215
+644
+1% +$8.97K ﹤0.01% 3484
2023
Q4
$1.22M Buy
63,571
+468
+0.7% +$11.4K ﹤0.01% 3439
2023
Q3
$1.7M Buy
63,103
+1,468
+2% +$63.6K ﹤0.01% 3393
2023
Q2
$2.79M Buy
61,635
+27,386
+80% +$1.34M ﹤0.01% 3262
2023
Q1
$1.56M Buy
34,249
+522
+2% +$27K ﹤0.01% 3406
2022
Q4
$1.77M Buy
33,727
+2,153
+7% +$127K ﹤0.01% 3412
2022
Q3
$3.65M Buy
31,574
+455
+1% +$40.5K ﹤0.01% 3210
2022
Q2
$1.88M Buy
31,119
+11,297
+57% +$849K ﹤0.01% 3500
2022
Q1
$1.11M Buy
19,822
+10,594
+115% +$877K ﹤0.01% 3773
2021
Q4
$704K Buy
9,228
+3,030
+49% +$353K ﹤0.01% 3903
2021
Q3
$872K Buy
+6,198
New +$727K ﹤0.01% 3808

Other funds holding RLYB

State Street's RLYB Position: Q1 2026 in Review

State Street sold out of Rallybio (RLYB) in Q1 2026, closing a stake of 7,759 shares — an estimated $42.6K sold.

State Street first reported a position in RLYB in Q3 2021 and held it in 18 quarters. The position peaked at $3.65M in Q3 2022. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • State Street reported no remaining Rallybio position as of Q1 2026 after selling out during the quarter.
  • State Street sold 7,759 Rallybio shares in Q1 2026, an estimated $42.6K.
  • State Street first reported a position in Rallybio in Q3 2021 and held it in 18 quarters.
  • State Street's Rallybio position peaked at $3.65M in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.